Clinical trialNCT04594642Active, not recruitingPhase 1Interventional

A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma

SponsorAstraZenecaEnrollment226B-cell Non Hodgkin LymphomaDiffuse Large B Cell LymphomaFollicular LymphomaHigh-grade B-cell Lymphoma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

David Sermer, MD
AstraZeneca
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Research Site
Heidelberg, Australia
Research Site
Hobart, Australia
Research Site
Melbourne, Australia

Japan

Research Site
Chūōku, Japan
Research Site
Kōtoku, Japan
Research Site
Nagoya, Japan
Research Site
Yamagata, Japan

South Korea

Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea

Taiwan

Research Site
Kaohsiung City, Taiwan
Research Site
Kweishan, Taiwan
Research Site
Tainan, Taiwan
Research Site
Taipei, Taiwan

United States

Research Site
Tampa, Florida, United States
Research Site
Louisville, Kentucky, United States
Research Site
New Brunswick, New Jersey, United States
Research Site
Charlotte, North Carolina, United States
Research Site
Columbus, Ohio, United States
Research Site
Pittsburgh, Pennsylvania, United States
Research Site
Austin, Texas, United States
Research Site
Houston, Texas, United States
Research Site
Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 2 Mar 2021
Primary completion: 19 Jun 2028
Completion: 19 Jun 2028
Last update posted: 17 Jun 2026
Registered enrollment: 226
Registry id: NCT04594642

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.